Compositions – Liquid crystal compositions – Containing nonsteryl liquid crystalline compound of...
Patent
1992-09-17
1994-11-01
Wu, Shean
Compositions
Liquid crystal compositions
Containing nonsteryl liquid crystalline compound of...
25229962, 25229963, 25229966, 25229967, 548237, C09K 1934, C09K 1930, C09K 1920, C07D 2610
Patent
active
053605772
ABSTRACT:
Optically active compounds of the general formula ##STR1## wherein n stands for the number 0 or 1; R.sup.3 denotes a group R.sup.4 or a group of the general formula ##STR2## A.sup.1, A.sup.2 and A.sup.3 each independently represent 1,4-phenylene, which is unsubstituted or mono- or multiply-substituted with halogen, cyano and/or methyl and in which, where it is unsubstituted, 1 or 2 CH groups is/are optionally replaced by nitrogen, trans-1,4-cyclohexylene, trans-1,3-dioxane-2,5-diyl, bycyclo[2.2.2]octane-1,4-diyl, naphthalene-2,6-diyl, tetralin-2,6-diyl or trans-decalin-2,6-diyl; Z.sup.1 and Z.sup.4 each independently signify a single covalent bond or --CH.sub.2 CH.sub.2 --; Z.sup.2 and Z.sup.3 each independently denote a single covalent bond, --CH.sub.2 CH.sub.2 --, --COO--, --OOC--, --CH.sub.2 O--, --OCH.sub.2 --, --C.tbd.C--, --(CH.sub.2).sub.4 --, --(CH.sub.2).sub.3 O--, --O(CH.sub.2).sub.3 -- or the trans form of --CH.dbd.CH--CH.sub.2 CH.sub.2 --, --CH.sub.2 CH.sub.2 --CH.dbd.CH--, --CH.dbd.CH--CH.sub.2 O-- or --OCH.sub.2 --CH.dbd.CH--; R.sup.1 and R.sup.5 each independently signify alkyl with 1 to 12 carbon atoms, alkoxymethyl with 2 to 12 carbon atoms, p-alkoxyphenyl or p-alkoxybenzyl; R.sup.2 and R.sup.6 each independently signify hydrogen, alkyl with 1 to 12 carbon atoms or phenyl; R.sup.4 denotes hydrogen, halogen, cyano, trifluoromethyl, trifluoromethoxy or alkyl or alkenyl with 1 to 12 and, respectively, 2 to 12 carbon atoms, which are unsubstituted or mono- or multiply-substituted with halogen, cyano and/or methyl and in which one methylene group or two non-adjacent methylene groups can be replaced by --O--, --COO-- and/or --OOC--; and the oxazoline ring in formula I is present in optically active form, liquid crystalline mixtures which contain such dopants and their use for optical and electro-optical purposes.
REFERENCES:
patent: 4264148 (1981-04-01), Gobl-Wunsch et al.
patent: 5159084 (1992-10-01), Shoshi
"Synthesis of Optically Active Bis(2-oxazolines): Crystal Structure of 1,2-Bis-(2-oxazolinyl)benzene.ZnCl.sub.2 Complex", Bolm et al.
Chem. Ber. 124, 1173-1180 (May 1991).
Derwent Abstract E13 L03 U11 V07 (1987) for DE-3744024.
Derwent Abstract E15 L03 U11 V07 (E14) (1989) for JP-027517.
Derwent Abstract E19 L03 (1989) for JP-023693.
Derwent Abstract AB9 E14 L03 (E13 E24) (1989) for DE-904797.
Derwent Abstract E13 L03 (E16) (1987) for JP-242077.
Derwent Abstract A32 E13 F01 (A23) (1986) for JP-017325.
Buchecker Richard
Kelly Stephen
Epstein William H.
Gould George M.
Hoffmann-La Roche Inc.
Tramaloni Dennis P.
Wu Shean
LandOfFree
Oxaxoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxaxoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxaxoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1800989